An exploratory study of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive metastatic breast cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Fátima Cardoso |
| Publication date | September 27, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |